SIBOLD WILLIAM JOHN (President and CEO) sold 6.6% of their position (7.28K shares) of MADRIGAL PHARMACEUTICALS, INC. on the open market
Open‑market sale worth $3.24M — a moderate reduction. Review remaining holdings and any 10b5‑1 plan disclosures.
S · 1 sale
Filed: 9/9/2025ACC: 0001518611-25-000009
DirectorOfficer· President and CEO
Since Mar 2026
-7.28K
Net shares
Net seller
$3.24M
Total sold
1
Open market trades
0B · 1S
1
Total transactions
7.28K disposed
Non-Derivative Transactions1
Common Stock
Direct
Shares
−7.28K
Price / share
$445.63
Trade value
$3.24M
% of position
6.6%
9/9/2025
109.75K→102.47K
Total
Net shares
−7.28K
Net value
-$3.24M
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Common Stock Direct | 9/9/2025 | S · Sale | −7.28K | $445.63 | $3.24M | 6.6% | 109.75K | 102.47K |
| Total | −7.28K | -$3.24M | ||||||
Derivative Transactions0
No derivative transactions reported